[Latest] Global Aesthetics Injectables Market Size/Share Worth USD 35,976.2 Million by 2033 at a 9.8% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
August 13, 2024 00:30 ET
|
Custom Market Insights
Austin, TX, USA, Aug. 13, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Aesthetics Injectables Market Size, Trends and Insights By Product Type...
Akero Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
August 09, 2024 07:00 ET
|
Akero Therapeutics Inc.
-- Initiated Phase 3 SYNCHRONY Outcomes Trial of Lead Candidate Efruxifermin (EFX) in Patients with Compensated Cirrhosis (F4) Due to MASH -- Presented Poster and Late-breaking Oral Presentation on...
The Niche Research Report: Unleashing Potential with Breakthrough Innovations in Facial Injectables Market
August 05, 2024 09:00 ET
|
The Niche Research
Wilmington, Delaware, Aug. 05, 2024 (GLOBE NEWSWIRE) -- The facial injectables market is witnessing robust growth, driven by the rising demand for non-invasive aesthetic treatments. Trends indicate...
Vagus Nerve Stimulation Market Set to Surge to USD 1074.62 Million By 2032 | Increasing Incidences of Neurological Diseases Such as Migraine and Epilepsy Boost Market Growth
July 26, 2024 10:35 ET
|
SNS Insider pvt ltd
Austin, July 26, 2024 (GLOBE NEWSWIRE) -- The Vagus Nerve Stimulation Market Size was valued at USD 456.88 million in 2023 and is expected to reach USD 1074.62 million by 2032 and grow at a CAGR of...
DEADLINE ALERT for EXAI, AKRO, and MBUU: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
June 25, 2024 09:48 ET
|
The Law Offices of Frank R. Cruz
LOS ANGELES, June 25, 2024 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...
AKRO FINAL DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages Akero Therapeutics, Inc. Investors to Secure Counsel Before Important June 25 Deadline in Securities Class Action – AKRO
June 24, 2024 13:10 ET
|
The Rosen Law Firm PA
NEW YORK, June 24, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Akero Therapeutics, Inc. (NASDAQ: AKRO) between...
TUESDAY DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Akero Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - AKRO
June 23, 2024 10:17 ET
|
Robbins Geller Rudman & Dowd LLP
SAN DIEGO, June 23, 2024 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers of Akero Therapeutics, Inc. (NASDAQ: AKRO) common stock between September...
Deadline in 2 Days: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Deadline in Class Action Lawsuit Against Akero Therapeutics, Inc. (AKRO)
June 23, 2024 09:45 ET
|
Kessler Topaz Meltzer & Check LLP
RADNOR, Pa., June 23, 2024 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the...
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Akero Therapeutics, Inc. - AKRO
June 22, 2024 12:23 ET
|
Pomerantz LLP
NEW YORK, June 22, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Akero Therapeutics, Inc. (“Akero” or the “Company”) (NASDAQ: AKRO). Such...
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Akero Therapeutics
June 21, 2024 10:40 ET
|
Faruqi & Faruqi LLP
NEW YORK, June 21, 2024 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Akero Therapeutics, Inc. (“Akero” or the...